Method for preparing upconversion-luminescence flexible hybrid membrane for visual detection of tumor marker

Patent metadata

Field	Value
Publication number	US-11041857-B2
Application number	US-201917044495-A
Country	US
Kind code	B2
Filing date	Apr 3, 2019
Priority date	Mar 25, 2019
Publication date	Jun 22, 2021
Grant date	Jun 22, 2021

Abstract

A method for preparing an upconversion-luminescence flexible hybrid membrane for visual detection of tumor markers is provided. Metal ion doped black phosphorus quantum dots (M-BPQDs) are prepared by adopting ultrasonic and solvothermal processes; mesoporous SiO2 grows on the surfaces of the M-BPQDs and amination modification is performed; the M-BPQDs are connected with carboxylated single-stranded DNA1; receptor molecules enter pores; single-stranded DNA2 aptamers and the DNA1 are combined due to base complementation to encapsulate receptors in the pores; and an M-BPQDs probe is prepared. DNA1 terminal-SH and a composite membrane are formed by assembling polymethyl methacrylate-polyimide-gold nanoparticles in a layer-by-layer manner bound by Au—S bonds, and the membrane and the probe are connected to construct the flexible hybrid membrane. The new flexible hybrid membrane is simple and inexpensive to prepare and is highly sensitive.

First claim

What is claimed is:

1. A method for preparing an upconversion-luminescence flexible hybrid membrane for a visual detection of a tumor marker, comprising the following steps:
(1) grinding a block black phosphorus crystal into powder, adding the powder to a polar solvent to obtain a first mixture, wherein a metal salt is dissolved in the polar solvent, ultrasonically stripping black phosphorus nanosheets from the first mixture by a probe and a bath, adding a thiol ligand to the black phosphorus nanosheets to obtain a second mixture, and preparing metal ion doped black phosphorus quantum dots (M-BPQDs) from the second mixture by an ultrasonic-assisted solvothermal treatment;
(2) growing mesoporous silica (mSiO 2 ) on surfaces of the M-BPQDs according to a Stöber method to obtain a third mixture, conducting an amination modification to introduce a —NH 2 modification on the third mixture to prepare M-BPQDs/mSiO 2 —NH 2 , and binding the M-BPQDs/mSiO 2 —NH 2 to a single-stranded DNA1 of the formula HS-DNA1-COOH by a carboxy-amine coupling to prepare M-BPQDs/mSiO 2 @DNA1;
(3) allowing a receptor molecule to enter a pore of the mSiO 2 to complete a loading of the receptor molecule, adding a specific aptamer single-stranded DNA2 for a complementary base pairing with the single-stranded DNA1 to form a double helix structure, and encapsulating the receptor molecule to obtain a nano-hybrid carrier probe M-BPQDs/mSiO 2 @DNA1-DNA2@receptor, wherein the receptor in the nano-hybrid carrier probe M-BPQDs/mSiO 2 @DNA1-DNA2@receptor is the receptor molecule, and the receptor molecule is 5-fluorouracil, and the receptor molecule is encapsulated in a pore of the mSiO 2 ;
(4) using polymethyl methacrylate (PMMA) as a layered substrate, bonding a layer of polyimide (PI) on a surface of a PMMA layer to obtain a PMAA-PI film, using an electrode clip to fix the PMAA-PI film to obtain an electrode clip fixed PMAA-PI film and immersing the electrode clip fixed PMAA-PI film in an electrolyte; using a KCl saturated calomel electrode as a reference electrode, a platinum wire electrode as an auxiliary electrode, and the PMMA-PI film as a working electrode, adding HAuCl 4 to the electrolyte, scanning the reference electrode, the auxiliary electrode and the working electrode by cyclic voltammetry, and electrochemically reducing a surface of the PMAA-PI film to form a layer of gold nanoparticles (AuNPs) to prepare a PMMA-PI-AuNPs composite film; and
(5) bonding the terminal sulfhydryl group of the single-stranded DNA1 on the nano-hybrid carrier probe to the AuNPs on the PMMA-PI-AuNPs composite film by Au—S bonds, and connecting the PMMA-PI-AuNPs composite film and the nano-hybrid carrier probe together to construct the upconversion-luminescence flexible hybrid membrane.

2. The method according to claim 1 , wherein the metal ion in step (1) is Ag+, Mn 2+ , Co 2+ , or Ni 2+ ; and the M-BPQDs are 1-5 nm in size.

3. The method according to claim 1 , wherein a thickness of the mSiO 2 on the surfaces of the M-BPQDs in step (2) is 50-200 nm.

4. The method according to claim 1 , wherein the specific aptamer single-stranded DNA2 is a single-stranded DNA aptamer specifically binding to the tumor marker, wherein the tumor marker is carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), carbohydrate antigen (CA), or prostate specific antigen (PSA).

5. The method according to claim 1 , wherein in step (4), a thickness of the PMMA layer is 50-100 nm, a thickness of the layer of PI is 1-2 μm, and a thickness of the layer of AuNPs is 10-100 nm.

6. A method for preparing an upconversion-luminescence flexible hybrid membrane for a visual detection of a tumor marker, comprising the following steps:
(1) grinding a block black phosphorus crystal into powder, adding the powder to a polar solvent to obtain a first mixture, wherein a metal salt is dissolved in the polar solvent, ultrasonically stripping black phosphorus nanosheets from the first mixture by a probe and a bath, adding a thiol ligand to the black phosphorus nanosheets to obtain a second mixture, and preparing metal ion doped black phosphorus quantum dots (M-BPQDs) from the second mixture by an ultrasonic-assisted solvothermal treatment;
(2) growing mesoporous silica (mSiO 2 ) on surfaces of the M-BPQDs according to a Stöber method to obtain a third mixture, conducting an amination modification to introduce a —NH 2 modification on the third mixture to prepare M-BPQDs/mSiO 2 —NH 2 , and binding the M-BPQDs/mSiO 2 —NH 2 to a single-stranded DNA1 of the formula HS-DNA1-COOH by a carboxy-amine coupling to prepare M-BPQDs/mSiO 2 @DNA1;
(3) allowing a receptor molecule to enter a pore of the mSiO 2 to complete a loading of the receptor molecule, adding a specific aptamer single-stranded DNA2 for a complementary base pairing with the single-stranded DNA1 to form a double helix structure, and encapsulating the receptor molecule to obtain a nano-hybrid carrier probe M-BPQDs/mSiO 2 @DNA1-DNA2@receptor, wherein the receptor in the nano-hybrid carrier probe M-BPQDs/mSiO 2 @DNA1-DNA2@receptor is the receptor molecule, and the receptor molecule is dopamine, and the receptor molecule is encapsulated in a pore of the mSiO 2 ;
(4) using polymethyl methacrylate (PMMA) as a layered substrate, bonding a layer of polyimide (PI) on a surface of a PMMA layer to obtain a PMAA-PI film, using an electrode clip to fix the PMAA-PI film to obtain an electrode clip fixed PMAA-PI film and immersing the electrode clip fixed PMAA-PI film in an electrolyte; using a KCl saturated calomel electrode as a reference electrode, a platinum wire electrode as an auxiliary electrode, and the PMMA-PI film as a working electrode, adding HAuCl 4 to the electrolyte, scanning the reference electrode, the auxiliary electrode and the working electrode by cyclic voltammetry, and electrochemically reducing a surface of the PMAA-PI film to form a layer of gold nanoparticles (AuNPs) to prepare a PMMA-PI-AuNPs composite film; and
(5) bonding the terminal sulfhydryl group of the single-stranded DNA1 on the nano-hybrid carrier probe to the AuNPs on the PMMA-PI-AuNPs composite film by Au—S bonds, and connecting the PMMA-PI-AuNPs composite film and the nano-hybrid carrier probe together to construct the upconversion-luminescence flexible hybrid membrane.

7. The method according to claim 6 , wherein the metal ion in step (1) is Ag + , Mn 2+ , Co 2+ , or Ni 2+ ; and the M-BPQDs are 1-5 nm in size.

8. The method according to claim 6 , wherein a thickness of the mSiO 2 on the surfaces of the M-BPQDs in step (2) is 50-200 nm.

9. The method according to claim 6 , wherein the specific aptamer single-stranded DNA2 is a single-stranded DNA aptamer specifically binding to the tumor marker, wherein the tumor marker is carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), carbohydrate antigen (CA), or prostate specific antigen (PSA).

10. The method according to claim 6 , wherein in step (4), a thickness of the PMMA layer is 50-100 nm, a thickness of the layer of PI is 1-2 μm, and a thickness of the layer of AuNPs is 10-100 nm.

11. A method for preparing an upconversion-luminescence flexible hybrid membrane for a visual detection of a tumor marker, comprising the following steps:
(1) grinding a block black phosphorus crystal into powder, adding the powder to a polar solvent to obtain a first mixture, wherein a metal salt is dissolved in the polar solvent, ultrasonically stripping black phosphorus nanosheets from the first mixture by a probe and a bath, adding a thiol ligand to the black phosphorus nanosheets to obtain a second mixture, and preparing metal ion doped black phosphorus quantum dots (M-BPQDs) from the second mixture by an ultrasonic-assisted solvot

Assignees

• Univ Qingdao

Inventors

• Jin Hui
• Gui Rijun
• Sun Yujiao
• Jiang Xiaowen

Classifications

• G01N33/5758

  involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites · CPC title

• G01N33/543 Primary

  with an insoluble carrier for immobilising immunochemicals · CPC title

• G01N21/64

  Fluorescence; Phosphorescence · CPC title

• G01N33/54393 Primary

  Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title

• C12N2310/16

  Aptamers · CPC title